Image Credit source: Technology Networks
Image Credit source: Technology Networks
Millions of people die every year from cancer. Cases of this disease are increasing continuously. Meanwhile, a ray of hope has also emerged in the treatment of rectal cancer. Recently, a research done in America has claimed to have cancer treatment. This study has been done on 18 patients suffering from rector cancer (cancer of the anus). All of them were given a drug called Dostarlimab. It was given to these patients for 6 months and due to this the cancer of the cancer was eliminated. Cancer was not found in PET SCAN, MRI and endoscopy examination. This research has been published in the New England Journal of Medicine. Scientists say that cancer has been eradicated with dosterlimab. The drug has proved effective on rector cancer. This is a major breakthrough in the history of cancer.
Now after this trial, dosterlimab medicine is being seen worldwide as a treatment for cancer. But will this drug prove to be effective on different types of cancer present in the body? Can it be assumed that now the cure for cancer has been found? to know Tv9 Has interacted with renowned cancer experts of the country
Dr. Devvrat Arya, Associate Director, Oncology Department of Max Hospital, Delhi, said that the trial of this drug has been done only on 18 patients and research of this drug has been done on only one type of cancer present in the body. In such a situation, it is not right to say that it will cure all types of cancer. Dr. said that dosterlimab is a monoclonal antibody drug. It exposes the cancer-causing cells. By which the immune system recognizes it and attacks it and the cancer ends, but not every type of cancer requires monoclonal antibodies. In trials conducted on patients with rectal cancer, scientists have used immunotherapy through this drug, but it is not necessary that this therapy proves to be effective in all types of cancer.
each type of cancer is different
Dr. Arya told that all cancers present in the body spread in different ways and there is a difference in their treatment. For example, immunotherapy is not effective in all types of breast cancer. Similarly, immunotherapy has no role in the early stages of cervical cancer. It is effective in this cancer when it comes back again. In oral cancer, immunotherapy is given in the fourth stage. In such a situation, on the basis of the study done only on rector cancer, it is not correct to say that dosterlimab medicine will be able to treat all types of cancer. Therefore the results of this trial may not be applicable to all cancer patients.
The reasons for the spread of cancer are also different
Dr. Anshuman Kumar, HOD, Department of Oncology, Dharamshila Narayana Superspeciality Hospital, Delhi said that rectal cancer changes the genes of the cell. Because of this, the body’s immune system does not recognize it and considers it to be such a normal cell. Cancer cells are exposed through this drug and the immune system attacks them, but other cancers that occur in the body are due to other reasons.
For example, cervical cancer in women is caused by the HPB virus. The immune system easily recognizes and eliminates this virus. Therefore, cases of cervical cancer are seen less in women with good immunity. In such a situation, no specific benefit of dostimab is seen in this type of cancer. In such a situation, it is not necessary that this drug can prove to be effective on all types of cancer.
just need to wait
Dr. says that this is a very small study and now these patients will have to be examined for at least five years. If cancer is not found in these patients after this period. Only then can it be said that a cure for cancer has been found in the form of dosterlimab. So people should not get too excited right now. Because only one dose of this medicine is worth about 9 lakh rupees. It is not easy to get such expensive treatment for all cancer patients in India.
Therefore, for the time being, the first to third phase trial will also have to wait. Only after that this drug will be considered effective, if this drug passes in all the trials, then it will be a big achievement in the history of a cancer. With this, the rector cancer patients will be treated easily and cancer will not be a fatal disease.